Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E83.92 EPS (ttm)0.65 Insider Own0.50% Shs Outstand1.74B Perf Week-0.05%
Market Cap95.02B Forward P/E19.50 EPS next Y2.80 Insider Trans-5.84% Shs Float1.72B Perf Month5.54%
Income1.06B PEG7.43 EPS next Q0.65 Inst Own74.10% Short Float0.87% Perf Quarter12.08%
Sales23.61B P/S4.03 EPS this Y-58.60% Inst Trans-0.02% Short Ratio2.72 Perf Half Y25.79%
Book/sh18.16 P/B3.01 EPS next Y12.31% ROA2.00% Target Price56.28 Perf Year33.93%
Cash/sh5.65 P/C9.66 EPS next 5Y11.29% ROE4.50% 52W Range37.38 - 55.43 Perf YTD42.23%
Dividend1.06 P/FCF64.99 EPS past 5Y0.00% ROI6.70% 52W High-1.44% Beta1.57
Dividend %1.94% Quick Ratio2.40 Sales past 5Y-0.50% Gross Margin54.20% 52W Low46.15% ATR0.69
Employees75000 Current Ratio2.90 Sales Q/Q24.50% Oper. Margin8.80% RSI (14)63.34 Volatility1.21% 1.30%
OptionableYes Debt/Eq0.76 EPS Q/Q-61.70% Profit Margin5.00% Rel Volume0.68 Prev Close54.65
ShortableYes LT Debt/Eq0.75 EarningsOct 18 BMO Payout145.50% Avg Volume5.51M Price54.63
Recom2.00 SMA202.16% SMA506.14% SMA20017.29% Volume3,725,800 Change-0.04%
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Oct-16-17 03:34PM  Top Research Reports for AbbVie, American Express & Abbott Zacks
10:13AM  Here's Why You Should Buy Thermo Fisher Scientific (TMO) Now Zacks
09:00AM  Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim DRG System PR Newswire
07:58AM  Here's Why Investors Should Buy Integra LifeSciences Now Zacks
07:57AM  TransEnterix Senhance Surgical Robotic System Wins FDA Nod Zacks
Oct-13-17 08:42AM  Abbott Banks on FDA Approvals and Buyouts, Competition Rife Zacks
07:38AM  Assessing Abbotts 3Q17 Expectations by Segment Market Realist
Oct-12-17 10:39AM  What to Expect from Abbott Laboratories 3Q17 Earnings Market Realist
09:11AM  Inside Abbotts 3Q17 Revenue Expectations: Hit or Miss? Market Realist
09:00AM  DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay Zacks
07:41AM  Abbotts Analyst Recommendations ahead of Its 3Q17 Results Market Realist
Oct-11-17 09:55AM  QIAGEN Banks on Tie-Ups & Product Launches, Competition Rife Zacks
09:54AM  Express Scripts (ESRX) to Buy eviCore, Fortify PBM Business Zacks
09:00AM  Is a Beat in Store for Abbott (ABT) This Earnings Season? Zacks
07:30AM  Dividend Coverage: This Healthcare Company has Paid Consecutive Quarterly Divided Since 1924; Will Trade Ex-Dividend on October 12, 2017 ACCESSWIRE
Oct-10-17 12:57PM  Pfizer weighs $15 bln sale of consumer healthcare business Reuters
09:45AM  Strategic Research Analysis ­ Positioning to Benefit on  Abbott, Rite Aid, Kroger, Celgene, Twitter, and NIKE ­ Effects of Key Drivers of Growth and Emerging Market Trends GlobeNewswire
09:34AM  QIAGEN Partners With CENTOGENE, Boosts Bioinformatics Suite Zacks
09:26AM  Illumina (ILMN) Strong on Product Launches, Competition Rife Zacks
Oct-09-17 01:26PM  DexCom's Quiet Consolidation After Huge Decline Benzinga
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Oct-08-17 09:23AM  News Flash: The FDA Just Approved a Breakthrough Diabetes Device Motley Fool
Oct-06-17 09:41AM  Abbott (ABT) Hits a 52-Week High: What's Driving the Stock? Zacks
Oct-05-17 03:35PM  Alere Inc. -- Moody's to withdraw Alere's ratings following debt redemption Moody's
08:51AM  Now, a brain pacemaker that reduces tremors and helps Parkinson's sufferers lead a more normal life CNBC
Oct-04-17 07:00PM  Cramer Remix: My mea culpa on DexCom and where its headed CNBC
08:00AM  Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
07:41AM  Behind Abbotts Recent Analyst Recommendation and Rating Upgrades Market Realist
Oct-03-17 10:40AM  Can Abbotts Latest Approval Accelerate Its Established Pharmaceuticals Business? Market Realist
09:10AM  Reading Abbotts FDA Approval for MR-Conditional Labeling for Its Ellipse ICD Market Realist
07:43AM  How Wall Street Reacted to the FDA Approval of Abbotts Freestyle Libre Market Realist
Oct-02-17 06:06PM  Abbotts Breakthrough CGM Device Freestyle Libre Wins FDA Approval Market Realist
04:45PM  Abbott to Gain from Alere's Takeover Due for Oct 3 Closure Zacks
04:36PM  Abbott-Alere Deal Wins Conditional US Antitrust Approval Market Realist
02:54PM  Whats Behind Abbotts 52-Week High Rally? Market Realist
10:09AM  Abbott Gets FDA Nod for FreeStyle Libre, Boosts Diabetes Arm Zacks
08:00AM  Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
Sep-29-17 01:44PM  Abbott Labs To Benefit From Freestyle Libre Flash Approval In The U.S. Forbes
01:28PM  Alere Reaches Settlement With SEC GuruFocus.com
10:50AM  Abbott's Ellipse ICD Receives FDA Approval for MRI Scans Zacks
10:31AM  Abbott Labs' Torturous Deal Saga Isn't Over Yet Bloomberg
09:20AM  Abbott Acquisition of Alere Set to Close on Tuesday, October 3, 2017 PR Newswire
08:20AM  Today's Research Reports on Stocks to Watch: Abbott Laboratories and DexCom ACCESSWIRE
05:51AM  [$$] Abbott Labs' Billion-Dollar Product Barrons.com
Sep-28-17 11:53PM  Asian shares slightly higher, though Japan is exception Associated Press
05:00PM  What Happened in the Stock Market Today Motley Fool
04:45PM  DexCom and Rite Aid tumble while Abbott and AbbVie rise Associated Press
03:42PM  The FDA just approved a device that can monitor blood sugar without finger pricks Business Insider
03:04PM  FTC Approves Abbott's Acquisition of Alere, Stock Jumps TheStreet.com
02:50PM  Abbott wins U.S. antitrust approval to buy Alere with conditions Reuters
02:20PM  Waltham's Alere settles SEC accounting fraud charges for $13M American City Business Journals
01:41PM  Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus TheStreet
01:28PM  Roku soars in its IPO & other big movers CNBC Videos
01:17PM  Buy Abbott Labs as It Obliterates DexCom Stock, Jim Cramer Says TheStreet.com
11:53AM  Why DexCom Stock Is Getting Crushed Today Motley Fool
11:48AM  Today's charts: Deutsche Bank thinks Facebook will rally; Blackberry shares jump; Abbott wins FDA approval Yahoo Finance
11:48AM  Abbott shares jump after approval for diabetes monitor; competitor DexCom crashes on surprise news CNBC
11:16AM  Go Long Abbott Laboratories on This Rise TheStreet.com
11:16AM  Abbott Laboratories Is Still Rising TheStreet.com
11:00AM  DexCom: Stay Sweet or Go Sour? Barrons.com
09:56AM  Cramer's Stop Trading: Abbott Labs CNBC Videos
08:45AM  Morning Movers: Endo Slumps, Hain Jumps, Philip Morris Rises Barrons.com
Sep-27-17 09:40PM  Abbott Labs gets FDA approval for diabetes device that doesn't require finger prick American City Business Journals
06:40PM  FDA approves Abbott's blood glucose monitoring device Reuters
06:28PM  FDA Approves First Finger Prick-Free Device for Diabetics Bloomberg
05:54PM  FDA approves Abbott's blood glucose monitoring device Reuters
05:42PM  No More Routine Finger Sticks(1) for Americans with Diabetes: Abbotts FreeStyle® Libre Approved in the U.S. PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-26-17 08:00AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
07:40AM  Featured Company News - FDA Approves Abbott's MRI-Compatible Ellipse ICDs ACCESSWIRE
Sep-22-17 03:30PM  Top Stock Reports for Caterpillar, Texas Instruments & Alphabet Zacks
09:35AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Now Zacks
08:00AM  Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse ICD PR Newswire
Sep-21-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-20-17 09:00AM  Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-19-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-18-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
08:00AM  Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. PR Newswire
07:39AM  Abbott Laboratories 375th Consecutive Quarterly Dividend Market Realist
Sep-15-17 12:06PM  The Latest Analyst Recommendations for Abbott Laboratories Market Realist
10:41AM  Abbott Gets UK Reimbursement Approval for Freestyle Libre Market Realist
08:46AM  Abbotts Amplatzer Device Affirms Reduced Recurrent Stroke Rates Market Realist
Sep-14-17 12:28PM  Abbott Declares 375th Consecutive Quarterly Dividend PR Newswire
10:31AM  How Safe Is Abbott Labs' Dividend? Motley Fool
10:01AM  Abbott's (ABT) FreeStyle Libre Gets UK Reimbursement Nod Zacks
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-13-17 08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
07:00AM  FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service PR Newswire
Sep-12-17 10:31AM  3 Big Stock Charts for Tuesday: Abbott Laboratories (ABT), Aetna Inc (AET) and Boston Scientific Corporation (BSX) InvestorPlace
08:01AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-11-17 10:06AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-08-17 04:08PM  4 Top MedTech Stocks for Dividend Investors in 2017 Zacks
10:21AM  See what the IHS Markit Score report has to say about Abbott Laboratories. Markit
Sep-07-17 11:54AM  ETFs with exposure to Abbott Laboratories : September 7, 2017 Capital Cube
11:49AM  Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index (DJSI) PR Newswire
10:19AM  Abbott (ABT) Hits a 52-Week High: What's Driving the Stock? Zacks
Sep-06-17 12:30PM  Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead Zacks
Sep-05-17 02:06PM  Abbott Laboratories :ABT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
10:12AM  Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief TheStreet.com
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Option Exercise44.3162,4602,767,646141,745Sep 28 05:13 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale52.9562,4603,307,25779,285Sep 28 05:13 PM
Contreras JaimeSenior Vice PresidentSep 22Option Exercise25.2952,7001,333,03798,039Sep 26 05:47 PM
Contreras JaimeSenior Vice PresidentSep 22Sale51.9752,7002,738,60345,339Sep 26 05:47 PM
Fussell Stephen RExecutive Vice PresidentAug 16Option Exercise25.56196,5505,023,939378,688Aug 18 05:10 PM
Fussell Stephen RExecutive Vice PresidentAug 16Sale49.50196,5509,729,225182,138Aug 18 05:10 PM
LIDDY EDWARD MDirectorAug 14Buy48.961,18558,01222,967Aug 22 05:04 PM
STARKS DANIEL JDirectorAug 02Option Exercise31.59504,54415,939,1526,943,248Aug 03 05:20 PM
Bracken Sharon JSenior Vice PresidentAug 01Sale49.162,00098,32327,206Aug 03 05:14 PM
Blaser Brian JExecutive Vice PresidentJul 27Sale50.0015,000750,000143,154Jul 28 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentJul 25Option Exercise26.704,600122,808105,479Jul 27 05:03 PM
ALLEN HUBERT LExecutive Vice PresidentJul 25Sale50.794,600233,647100,879Jul 27 05:03 PM
Watkin JaredSenior Vice PresidentJun 15Sale47.9755226,48246,538Jun 16 05:02 PM
Fussell Stephen RExecutive Vice PresidentJun 08Option Exercise25.56196,5505,023,939378,688Jun 09 05:04 PM
Fussell Stephen RExecutive Vice PresidentJun 08Sale46.00196,5509,041,360182,138Jun 09 05:04 PM
BIRD ROGERSenior Vice PresidentApr 27Sale43.825,600245,39351,313Apr 28 05:28 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Option Exercise26.703,20085,43126,224Apr 28 05:27 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Sale43.954,200184,59922,024Apr 28 05:27 PM
Contreras JaimeSenior Vice PresidentMar 31Sale44.6476734,2402,410Apr 04 05:02 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale45.391,72878,43463,425Mar 02 05:19 PM
NATH DEEPAK S.Senior Vice PresidentMar 01Sale45.391,60172,66951,430Mar 02 05:17 PM
Warmuth Michael JExecutive Vice PresidentMar 01Sale45.393,851174,79756,508Mar 02 05:04 PM
Watkin JaredSenior Vice PresidentMar 01Sale45.3997044,02848,511Mar 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentMar 01Sale45.392,06693,77672,112Mar 02 05:16 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 28Sale45.0185738,569100,879Mar 02 05:15 PM
BIRD ROGERSenior Vice PresidentFeb 28Sale45.021,60172,06956,913Mar 02 05:11 PM
Mason Heather LExecutive Vice PresidentFeb 28Sale45.011,91286,06859,677Mar 02 05:06 PM
Contreras JaimeSenior Vice PresidentFeb 28Sale45.0113,155592,15745,733Mar 02 05:05 PM
MANNING JOSEPH JSenior Vice PresidentFeb 28Sale44.9674433,45323,024Mar 02 05:18 PM
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM